Corpus Intelligence IC Memo — MERCY HEALTH LOURDES HOSPITAL LLC 2026-04-26 11:17 UTC
IC Memo — MERCY HEALTH LOURDES HOSPITAL LLC
Investment Committee Memorandum | KY | 178 beds | Grade B | EBITDA uplift $21.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MERCY HEALTH LOURDES HOSPITAL LLC

CCN 180102 | MC CRACKEN, KY | 178 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

MERCY HEALTH LOURDES HOSPITAL LLC is a 178-bed suburban community hospital in MC CRACKEN, KY with $288.1M in net patient revenue and a 7.7% operating margin. The hospital serves a payer mix of 32.6% Medicare, 0.9% Medicaid, and 66.5% commercial.

Thesis: Turnaround. Our ML models identify $21.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 7.7% to 15.1% (+736bps).

Net Revenue HCRIS$288.1M
Current EBITDA COMPUTED$22.3M
Operating Margin COMPUTED7.7%
Occupancy HCRIS63.7%
Revenue / Bed COMPUTED$1.6M
Net-to-Gross HCRIS22.9%
Distress Probability ML43.3%

2. Market Context & Competitive Position

114
KY Hospitals
-0.6%
State Median Margin
35
Comparable Hospitals

KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 7.7% places it above the state median. Among 35 size-comparable peers (89-356 beds), the median margin is -1.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (89-356), prioritizing same-state peers. 35 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MERCY HEALTH LOURDES HOSPITAL (Target)KY178$288.1M7.7%
UNIVERSITY OF LOUISVILLE HOSPIKY333$806.1M-6.9%
OWENSBORO HEALTH REGIONAL HOSPKY302$678.6M11.1%
PIKEVILLE MEDICAL CENTERKY328$555.1M-16.6%
BAPTIST HEALTH HARDINKY259$459.5M-1.5%
THE MEDICAL CENTERKY310$451.0M4.2%
BAPTIST HEALTH PADUCAHKY190$391.7M-0.5%
SAINT JOSEPH HOSPITALKY252$322.8M-17.3%
BAPTIST HEALTH CORBINKY197$285.4M1.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $21.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$6.0M+210bp18mo
Cost to Collect4.5%2.5%$5.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$5.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.5M+122bp9mo
Clean Claim Rate88.0%96.0%$184K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$6.0M
Cost to Collect
$5.8M
Denial Rate Reduction
$5.7M
A/R Days Reduction
$3.5M
Clean Claim Rate
$184K
Total EBITDA Uplift$21.2M
Current EBITDA$22.3M
+ RCM Uplift+$21.2M
Pro Forma EBITDA$43.5M
Current Margin7.7%
Pro Forma Margin15.1%
WC Released (1x)$11.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$34.3M$358.9M10.48x60.0%
Base (11x exit)10.0x11.0x$34.3M$406.0M11.85x64.0%
Bull Case9.0x11.0x$30.8M$487.1M15.80x73.7%
Bull (12x exit)9.0x12.0x$30.8M$540.4M17.53x77.3%
Bear Case11.0x10.0x$37.7M$241.8M6.42x45.0%
Bear (11x exit)11.0x11.0x$37.7M$278.2M7.38x49.2%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 35 hospitals with 89-356 beds
  • Same-state prioritization (n=36)
  • Comp margins: P25=-10.1% / P50=-1.5% / P75=5.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.